Published in TB and Outbreaks Week, October 22nd, 2002
A new Pharmacor report from Decision Resources, "Community-Acquired Pneumonia," concludes that generic erosion will be a major factor in the sales decrease.
"There are many drugs available to treat community-acquired pneumonia," said Margaret Jorgensen, PhD, analyst at Decision Resources. "Because of this market saturation, the growth potential of emerging agents to treat community-acquired pneumonia is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.